CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Nipro Corp is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Nipro Corp
3-26, Senrioka shin-machi
Phone: +81 663106909p:+81 663106909 SETTSU-SHI, OSK  566-8510  Japan Ticker: 80868086

Business Summary
NIPRO CORPORATION is a manufacturer of medical devices, pharmaceuticals and instrument products. The Company has three segments. The Medical-Related segment involves in the sale of injections and infusions, artificial organs, high function and dialysis related medical equipment, and diabetes, generics and kits related medicine products in Japan, as well as the sales of medical devices for injection and infusion, artificial organs and diabetes in overseas markets. The Pharmaceutical-Related segment involves in the manufacture and sale of pharmaceuticals. The Pharma Packaging segment sells glass for vials and ampoules as medical glass in Japan, thermos glass for lighting and glass for lighting equipment.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/20243/31/2024Yes---Yes

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
President, Representative Director YoshihikoSano 79 10/1/2012 6/1/2000
Senior Managing Director, Chief Director of Administration Supervision & Management Planning TakehitoYogo 55 11/1/2023 6/1/2018
Senior Managing Director, Director of Vascular Business, President of Subsidiary YasushiOhyama 61 4/1/2024 6/1/2013
12 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Goodman Co., Ltd. 5F KDX Nagoya Sakae Building Nagoya ACH Japan
Home Diagnostics, Inc. 2400 NW 55th Court Fort Lauderdale FL United States
Infraredx Inc 34 3rd Ave BURLINGTON MA United States
P. J. Noyes Company, Inc. 89 Bridge St. Lancaster NH United States

Business Names
Business Name
8086
Goodman Co., Ltd.
Goodman USA, Inc.
16 additional Business Names available in full report.

General Information
Number of Employees: 38,117 (As of 3/31/2024)
Outstanding Shares: 163,095,819 (As of 9/30/2024)
Shareholders: 62,816
Stock Exchange: TYO
Fax Number: +81 663717422
Email Address: customercare@niprodiagnostics.com


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, December 2, 2024